Exposure to blue light decreases blood pressure, reducing the risk of developing cardiovascular disease, a study has found.
For the study, published in the European Journal of Preventative Cardiology, participants were exposed to 30 minutes of whole-body blue light at approximately 450 nanometres, a dose comparable to daily sunlight -- followed by exposure to a control light on a different day.
To assess the impact, participants' blood pressure, stiffness of arteries, blood vessel dilation and blood plasma levels of nitric oxide stores were measured before, during, and up to two hours after irradiation with both lights.
Visible blue light, as opposed to ultraviolet (UV) light, is not carcinogenic.
Researchers from University of Surrey in the UK and Heinrich Heine University Dusseldorf in Germany discovered that exposure to whole-body blue light significantly reduced the systolic blood pressure of participants by almost 8 mmHg, compared to the control light which had no impact.
The reduction of blood pressure from blue light is similar to what is seen in clinical trials with blood pressure lowering drugs.
Besides blood pressure lowering effects, it was also uncovered that exposure to blue light improved other cardiovascular risk markers including reduction of arterial stiffness and increasing blood vessel relaxation.
This further supports that light could be used to prevent cardiovascular disease.
Researchers also found that exposure to blue light increased levels of nitric oxide which is an important signalling molecular that protects the cardiovascular system.
It is believed that blue light releases from the skin into the blood stream where it relaxes the blood vessels, increasing blood flow and decreasing blood pressure.
"Exposure to blue light provides an innovative method to precisely control blood pressure without drugs, said Christian Heiss, a professor at the University of Surrey.
"Wearable blue light sources could make continued exposure to light possible and practical. This would be particularly helpful to those whose blood pressure is not easily controlled by medication, such as older people," said Heiss.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)